COPAXONE
COPAXONE
Approved
DIN Number
02245619
Drug Class
Human
Market Date
May 1, 2002
Company
HC
teva canada limited
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02245619
AIG Number0132525001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L03AX13 GLATIRAMER ACETATE
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification92:20.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
GLATIRAMER ACETATEActive
Strength: 20 MG / ML
Monograph: GLATIRAMER ACETATE